Clin Colon Rectal Surg 2016; 29(01): 057-064
DOI: 10.1055/s-0035-1570394
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Screening, Surveillance, and Treatment of Anal Intraepithelial Neoplasia

Kevin C. Long
1   Swedish Colon and Rectal Clinic, Swedish Medical Center Department of Surgery, Seattle, Washington
,
Raman Menon
1   Swedish Colon and Rectal Clinic, Swedish Medical Center Department of Surgery, Seattle, Washington
,
Amir Bastawrous
1   Swedish Colon and Rectal Clinic, Swedish Medical Center Department of Surgery, Seattle, Washington
,
Richard Billingham
1   Swedish Colon and Rectal Clinic, Swedish Medical Center Department of Surgery, Seattle, Washington
› Author Affiliations
Further Information

Publication History

Publication Date:
16 February 2016 (online)

Abstract

The prevalence of anal intraepithelial neoplasia has been increasing, especially in high-risk patients, including men who have sex with men, human immunodeficiency virus positive patients, and those who are immunosuppressed. Several studies with long-term follow-up have suggested that rate of progression from high-grade squamous intraepithelial lesions to invasive anal cancer is ∼ 5%. This number is considerably higher for those at high risk. Anal cytology has been used to attempt to screen high-risk patients for disease; however, it has been shown to have very little correlation to actual histology. Patients with lesions should undergo history and physical exam including digital rectal exam and standard anoscopy. High-resolution anoscopy can be considered as well, although it is of questionable time and cost–effectiveness. Nonoperative treatments include expectant surveillance and topical imiquimod or 5-fluorouracil. Operative therapies include wide local excision and targeted ablation with electrocautery, infrared coagulation, or cryotherapy. Recurrence rates remain high regardless of treatment delivered and surveillance is paramount, although optimal surveillance regimens have yet to be established.

 
  • References

  • 1 Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62 (1) 10-29
  • 2 Fenger C, Nielsen VT. Intraepithelial neoplasia in the anal canal. The appearance and relation to genital neoplasia. Acta Pathol Microbiol Immunol Scand [A] 1986; 94 (5) 343-349
  • 3 National Cancer Institute, DCCPS, Surveillance Research Program SSB. Surveillance, Epidemiology, and End Results (SEER) Program. Available at: www.seer.cancer.gov . Research Data (1973–2012).
  • 4 Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst Monogr 1998; 23: 15-20
  • 5 Machalek DA, Poynten M, Jin F , et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012; 13 (5) 487-500
  • 6 Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol 2011; 119 (1) 5-19
  • 7 Frisch M, Glimelius B, van den Brule AJ , et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337 (19) 1350-1358
  • 8 Bowen J. Precancerous dermatoses: A study of two cases of chronic atypical epithelial proliferation. J Cutan Dis 1912; 30: 241-255
  • 9 Vickers P, Jackman R, McDonald J. Anal carcinoma in situ: report of three cases. South Surg 1939; 8: 503-507
  • 10 Turell R. Epidermoid squamous cell cancer of the perianus and anal canal. Surg Clin North Am 1962; 42: 1235-1241
  • 11 Oriel JD, Whimster IW. Carcinoma in situ associated with virus-containing anal warts. Br J Dermatol 1971; 84 (1) 71-73
  • 12 Fenger C, Nielsen VT. Dysplastic changes in the anal canal epithelium in minor surgical specimens. Acta Pathol Microbiol Scand [A] 1981; 89 (6) 463-465
  • 13 Zbar AP, Fenger C, Efron J, Beer-Gabel M, Wexner SD. The pathology and molecular biology of anal intraepithelial neoplasia: comparisons with cervical and vulvar intraepithelial carcinoma. Int J Colorectal Dis 2002; 17 (4) 203-215
  • 14 Stanley M. Chapter 17: Genital human papillomavirus infections—current and prospective therapies. J Natl Cancer Inst Monogr 2003; 117-124
  • 15 Carter PS, Sheffield JP, Shepherd N , et al. Interobserver variation in the reporting of the histopathological grading of anal intraepithelial neoplasia. J Clin Pathol 1994; 47 (11) 1032-1034
  • 16 Stoler MH, Vichnin MD, Ferenczy A , et al; FUTURE I, II and III Investigators. The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials. Int J Cancer 2011; 128 (6) 1354-1362
  • 17 Castle PE, Stoler MH, Solomon D, Schiffman M. The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. Am J Clin Pathol 2007; 127 (5) 805-815
  • 18 Darragh TM, Colgan TJ, Cox JT , et al; Members of LAST Project Work Groups. The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the college of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med 2012; 136 (10) 1266-1297
  • 19 Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17 (6) 1471-1474
  • 20 Ogunbiyi OA, Scholefield JH, Raftery AT , et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994; 81 (3) 365-367
  • 21 Palefsky JM, Holly EA, Hogeboom CJ , et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17 (4) 314-319
  • 22 Friedman HB, Saah AJ, Sherman ME , et al. Human papillomavirus, anal squamous intraepithelial lesions, and human immunodeficiency virus in a cohort of gay men. J Infect Dis 1998; 178 (1) 45-52
  • 23 Daling JR, Madeleine MM, Johnson LG , et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101 (2) 270-280
  • 24 Sendagorta E, Herranz P, Guadalajara H , et al. Prevalence of abnormal anal cytology and high-grade squamous intraepithelial lesions among a cohort of HIV-infected men who have sex with men. Dis Colon Rectum 2014; 57 (4) 475-481
  • 25 Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009; 52 (5) 611-622
  • 26 Devaraj B, Cosman BC. Expectant management of anal squamous dysplasia in patients with HIV. Dis Colon Rectum 2006; 49 (1) 36-40
  • 27 Pineda CE, Berry JM, Jay N, Palefsky JM, Welton ML. High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience. Dis Colon Rectum 2008; 51 (6) 829-835 , discussion 835–837
  • 28 de Pokomandy A, Rouleau D, Ghattas G , et al. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis 2011; 52 (9) 1174-1181
  • 29 Chin-Hong PV, Husnik M, Cranston RD , et al. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS 2009; 23 (9) 1135-1142
  • 30 Lacey CJN. Therapy for genital human papillomavirus-related disease. J Clin Virol 2005; 32 (Suppl. 01) S82-S90
  • 31 Adami J, Gäbel H, Lindelöf B , et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89 (7) 1221-1227
  • 32 Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 2006; 24 (3) (Suppl 3): 42-51 . doi:10.1016/j.vaccine.2006.06.018
  • 33 Muñoz N, Bosch FX, de Sanjosé S , et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993; 2 (5) 423-431
  • 34 Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009; 124 (10) 2375-2383
  • 35 Gohy L, Gorska I, Rouleau D , et al; HIPVIRG Study Group. Genotyping of human papillomavirus DNA in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia. J Acquir Immune Defic Syndr 2008; 49 (1) 32-39
  • 36 Watson AJM, Smith BB, Whitehead MR, Sykes PH, Frizelle FA. Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg 2006; 76 (8) 715-717
  • 37 Lacey HB, Wilson GE, Tilston P , et al. A study of anal intraepithelial neoplasia in HIV positive homosexual men. Sex Transm Infect 1999; 75 (3) 172-177
  • 38 Shvetsov YB, Hernandez BY, McDuffie K , et al. Duration and clearance of anal human papilloma infection among women: the Hawaii HPV cohort study. Clin Infect Dis 2009; 48 (5) 536-546
  • 39 Powles T, Robinson D, Stebbing J , et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009; 27 (6) 884-890
  • 40 Walts AE, Lechago J, Bose S. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia. Am J Surg Pathol 2006; 30 (7) 795-801
  • 41 Bala R, Pinsky BA, Beck AH, Kong CS, Welton ML, Longacre TA. p16 is superior to ProEx C in identifying high-grade squamous intraepithelial lesions (HSIL) of the anal canal. Am J Surg Pathol 2013; 37 (5) 659-668
  • 42 Pirog EC, Quint KD, Yantiss RK. P16/CDKN2A and Ki-67 enhance the detection of anal intraepithelial neoplasia and condyloma and correlate with human papillomavirus detection by polymerase chain reaction. Am J Surg Pathol 2010; 34 (10) 1449-1455
  • 43 Cranston RD, Darragh TM, Holly EA , et al. Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men. J Acquir Immune Defic Syndr 2004; 36 (4) 915-920
  • 44 Solomon D, Davey D, Kurman R , et al; Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287 (16) 2114-2119
  • 45 Chin-Hong PV, Berry JM, Cheng SC , et al. Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med 2008; 149 (5) 300-306
  • 46 Mathews WC, Sitapati A, Caperna JC, Barber RE, Tugend A, Go U. Measurement characteristics of anal cytology, histopathology, and high-resolution anoscopic visual impression in an anal dysplasia screening program. J Acquir Immune Defic Syndr 2004; 37 (5) 1610-1615
  • 47 Betancourt EM, Wahbah MM, Been LC, Chiao EY, Citron DR, Laucirica R. Anal cytology as a predictor of anal intraepithelial neoplasia in HIV-positive men and women. Diagn Cytopathol 2013; 41 (8) 697-702
  • 48 Panther LA, Wagner K, Proper J , et al. High resolution anoscopy findings for men who have sex with men: inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and the impact of HIV serostatus. Clin Infect Dis 2004; 38 (10) 1490-1492
  • 49 Nahas CSR, da Silva Filho EV, Segurado AAC , et al. Screening anal dysplasia in HIV-infected patients: is there an agreement between anal pap smear and high-resolution anoscopy-guided biopsy?. Dis Colon Rectum 2009; 52 (11) 1854-1860
  • 50 Weis SE, Vecino I, Pogoda JM , et al. Prevalence of anal intraepithelial neoplasia defined by anal cytology screening and high-resolution anoscopy in a primary care population of HIV-infected men and women. Dis Colon Rectum 2011; 54 (4) 433-441
  • 51 Berry JM, Palefsky JM, Jay N, Cheng SC, Darragh TM, Chin-Hong PV. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum 2009; 52 (2) 239-247
  • 52 O'Connor JJ. The study of anorectal disease by colposcopy. Dis Colon Rectum 1977; 20 (7) 570-572
  • 53 Tramujas da Costa e Silva I, de Lima Ferreira LC, Santos Gimenez F , et al. High-resolution anoscopy in the diagnosis of anal cancer precursor lesions in renal graft recipients. Ann Surg Oncol 2008; 15 (5) 1470-1475
  • 54 Jay N, Berry JM, Hogeboom CJ, Holly EA, Darragh TM, Palefsky JM. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum 1997; 40 (8) 919-928
  • 55 Pineda CE, Berry JM, Welton ML. High resolution anoscopy and targeted treatment of high-grade squamous intraepithelial lesions. Dis Colon Rectum 2006; 49 (1) 126
  • 56 Chung AP, Rosenfeld DB. Intraoperative high-resolution anoscopy: a minimally invasive approach in the treatment of patients with Bowen's disease and results in a private practice setting. Am Surg 2007; 73 (12) 1279-1283
  • 57 Abbasakoor F, Boulos PB. Anal intraepithelial neoplasia. Br J Surg 2005; 92 (3) 277-290
  • 58 Jay N, Berry JM, Hogeboom CJ, Holly EA, Darragh TM, Palefsky JM. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum 1997; 40 (8) 919-928
  • 59 Chang GJ, Berry JM, Jay N, Palefsky JM, Welton ML. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum 2002; 45 (4) 453-458
  • 60 Steele SR, Varma MG, Melton GB, Ross HM, Rafferty JF, Buie WD ; Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for anal squamous neoplasms. Dis Colon Rectum 2012; 55 (7) 735-749
  • 61 Crawshaw BP, Russ AJ, Stein SL , et al. High-resolution anoscopy or expectant management for anal intraepithelial neoplasia for the prevention of anal cancer: is there really a difference?. Dis Colon Rectum 2015; 58 (1) 53-59
  • 62 Mahto M, Nathan M, O'Mahony C. More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia. Int J STD AIDS 2010; 21 (1) 8-16
  • 63 Richel O, Wieland U, de Vries HJC , et al. Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men. Br J Dermatol 2010; 163 (6) 1301-1307
  • 64 Franceschi S, De Vuyst H. Human papillomavirus vaccines and anal carcinoma. Curr Opin HIV AIDS 2009; 4 (1) 57-63
  • 65 Palefsky JM, Giuliano AR, Goldstone S , et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365 (17) 1576-1585
  • 66 Strauss RJ, Fazio VW. Bowen's disease of the anal and perianal area. A report and analysis of twelve cases. Am J Surg 1979; 137 (2) 231-234
  • 67 Margenthaler JA, Dietz DW, Mutch MG, Birnbaum EH, Kodner IJ, Fleshman JW. Outcomes, risk of other malignancies, and need for formal mapping procedures in patients with perianal Bowen's disease. Dis Colon Rectum 2004; 47 (10) 1655-1660 , discussion 1660–1661
  • 68 Reynolds VH, Madden JJ, Franklin JD, Burnett LS, Jones III HW, Lynch JB. Preservation of anal function after total excision of the anal mucosa for Bowen's disease. Ann Surg 1984; 199 (5) 563-568
  • 69 Marchesa P, Fazio VW, Oliart S, Goldblum JR, Lavery IC. Perianal Bowen's disease: a clinicopathologic study of 47 patients. Dis Colon Rectum 1997; 40 (11) 1286-1293
  • 70 Pineda CE, Berry JM, Jay N, Palefsky JM, Welton ML. High resolution anoscopy in the planned staged treatment of anal squamous intraepithelial lesions in HIV-negative patients. J Gastrointest Surg 2007; 11 (11) 1410-1415 , discussion 1415–1416
  • 71 Goldstone RN, Goldstone AB, Russ J, Goldstone SE. Long-term follow-up of infrared coagulator ablation of anal high-grade dysplasia in men who have sex with men. Dis Colon Rectum 2011; 54 (10) 1284-1292
  • 72 Park IU, Palefsky JM. Evaluation and management of anal intraepithelial neoplasia in HIV-negative and HIV-positive men who have sex with men. Curr Infect Dis Rep 2010; 12 (2) 126-133